112 related articles for article (PubMed ID: 11595346)
41. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
Ding YS; Lin KS; Logan J; Benveniste H; Carter P
J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
[TBL] [Abstract][Full Text] [Related]
42. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
Zhu MY; Shamburger S; Li J; Ordway GA
J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
[TBL] [Abstract][Full Text] [Related]
43. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter.
Jayanthi LD; Prasad PD; Ramamoorthy S; Mahesh VB; Leibach FH; Ganapathy V
Biochemistry; 1993 Nov; 32(45):12178-85. PubMed ID: 8218295
[TBL] [Abstract][Full Text] [Related]
44. (R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake.
Gehlert DR; Hemrick-Luecke SK; Schober DA; Krushinski J; Howbert JJ; Robertson DW; Wong DT; Fuller RW
Life Sci; 1995; 56(22):1915-20. PubMed ID: 7746100
[TBL] [Abstract][Full Text] [Related]
45. Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo.
Heidbreder CA; Bianchi M; Lacroix LP; Faedo S; Perdona E; Remelli R; Cavanni P; Crespi F
Synapse; 2003 Dec; 50(4):269-76. PubMed ID: 14556231
[TBL] [Abstract][Full Text] [Related]
46. Cocaine up-regulates norepinephrine transporter binding in the rat placenta.
Shearman LP; Meyer JS
Eur J Pharmacol; 1999 Dec; 386(1):1-6. PubMed ID: 10611457
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
Foley KF; Cozzi NV
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
[TBL] [Abstract][Full Text] [Related]
49. Placental norepinephrine transporter development in the ovine fetus.
Bzoskie I; Blount I; Kashiwai K; Humme J; Padbury JF
Placenta; 1997 Jan; 18(1):65-70. PubMed ID: 9032811
[TBL] [Abstract][Full Text] [Related]
50. Noradrenergic terminals are the primary source of α
Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
[TBL] [Abstract][Full Text] [Related]
51. chi-Conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter.
Bryan-Lluka LJ; Bönisch H; Lewis RJ
J Biol Chem; 2003 Oct; 278(41):40324-9. PubMed ID: 12837768
[TBL] [Abstract][Full Text] [Related]
52. Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.
Annamalai B; Mannangatti P; Arapulisamy O; Ramamoorthy S; Jayanthi LD
J Neurochem; 2010 Oct; 115(1):23-35. PubMed ID: 20626559
[TBL] [Abstract][Full Text] [Related]
53. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation.
Hahn MK; Mazei-Robison MS; Blakely RD
Mol Pharmacol; 2005 Aug; 68(2):457-66. PubMed ID: 15894713
[TBL] [Abstract][Full Text] [Related]
54. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
Tejani-Butt SM
J Pharmacol Exp Ther; 1992 Jan; 260(1):427-36. PubMed ID: 1731049
[TBL] [Abstract][Full Text] [Related]
55. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
[TBL] [Abstract][Full Text] [Related]
56. chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.
Paczkowski FA; Sharpe IA; Dutertre S; Lewis RJ
J Biol Chem; 2007 Jun; 282(24):17837-44. PubMed ID: 17428804
[TBL] [Abstract][Full Text] [Related]
57. α2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells.
Park JW; Chung HW; Lee EJ; Jung KH; Paik JY; Lee KH
Neurosci Lett; 2013 Apr; 541():184-9. PubMed ID: 23485735
[TBL] [Abstract][Full Text] [Related]
58. Functional significance of a highly conserved glutamate residue of the human noradrenaline transporter.
Sucic S; Paczkowski FA; Runkel F; Bönisch H; Bryan-Lluka LJ
J Neurochem; 2002 Apr; 81(2):344-54. PubMed ID: 12064482
[TBL] [Abstract][Full Text] [Related]
59. The norepinephrine transporter in physiology and disease.
Bönisch H; Brüss M
Handb Exp Pharmacol; 2006; (175):485-524. PubMed ID: 16722247
[TBL] [Abstract][Full Text] [Related]
60. Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells.
Obara G; Toyohira Y; Inagaki H; Takahashi K; Horishita T; Kawasaki T; Ueno S; Tsutsui M; Sata T; Yanagihara N
J Pharmacol Sci; 2013; 121(2):138-47. PubMed ID: 23370666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
